The University of Chicago Header Logo

Connection

Thomas F. Gajewski to Adenocarcinoma

This is a "connection" page, showing publications Thomas F. Gajewski has written about Adenocarcinoma.
Connection Strength

0.056
  1. The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer. Prostate. 2009 Feb 01; 69(2):142-8.
    View in: PubMed
    Score: 0.048
  2. A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer. Lung Cancer. 2003 Feb; 39(2):191-6.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.